ROLE OF HYPERURICEMIA AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM ACTIVATION IN RENAL DYSFUNCTION
Keywords:
This study is dedicated to investigating hyperuricemia and its associated renal dysfunction mechanisms. Hyperuricemia, characterized by elevated uric acid levels, induces oxidative stress, inflammation, and tubulointerstitial injury. In addition, activation of the renin-angiotensin-aldosterone system (RAAS) exacerbates glomerular and tubular damage, leading to proteinuria, interstitial fibrosis, and glomerulosclerosis. Experimental and clinical studies demonstrate that lowering uric acid levels and modulating RAAS can prevent the decline in kidney function and slow the progression of chronic kidney disease. The results of this work can be applied in the treatment and prevention of patients with hyperuricemia, as well as in guiding clinical management strategies.Abstract
This study is dedicated to investigating hyperuricemia and its associated renal dysfunction mechanisms. Hyperuricemia, characterized by elevated uric acid levels, induces oxidative stress, inflammation, and tubulointerstitial injury. In addition, activation of the renin-angiotensin-aldosterone system (RAAS) exacerbates glomerular and tubular damage, leading to proteinuria, interstitial fibrosis, and glomerulosclerosis. Experimental and clinical studies demonstrate that lowering uric acid levels and modulating RAAS can prevent the decline in kidney function and slow the progression of chronic kidney disease. The results of this work can be applied in the treatment and prevention of patients with hyperuricemia, as well as in guiding clinical management strategies.
Downloads
References
1. Johnson, R. J., Nakagawa, T., Jalal, D., Sanchez-Lozada, L. G., Kang, D. H., & Ritz, E. (2013). Uric acid and chronic kidney disease: Which is chasing which? Nephrology Dialysis Transplantation, 28(9), 2221–2228.
2. Nakagawa, T., Cirillo, P., Sato, W., Kawamoto, R., Higa, S., Andres-Hernando, A., ... & Johnson, R. J. (2015). The role of uric acid in the progression of chronic kidney disease. American Journal of Kidney Diseases, 66(6), 927–937.
3. Maksudov, D., Azimova, A., & Mamadyarova, S. (2021). Clinical course of inflammatory diseases of the maxillofacial region in patients with viral hepatitis b. Збірник наукових праць ΛΌГOΣ.–2021.
4. Su, H.-Y., Yang, C., Liang, D., & Liu, H.-F. (2020). Research advances in the mechanisms of hyperuricemia-induced renal injury. BioMed Research International, 2020, 1–12.
5. Russo, E., Verzola, D., & Viazzi, F. (2021). The role of uric acid in renal damage: inflammatory pathways and vascular remodeling. Vessel Plus, 5, 1–12.
